Bipartisan Backlash on Drug Prices Prompts One Company to Cash Out

Jeffrey Aronin hoped to eventually sell Marathon Pharmaceuticals for billions of dollars, but then the company said it would charge $89,000 a year for a muscular-dystrophy drug.

from WSJ.com: US Business http://ift.tt/2ptQycg
via IFTTT